Black Diamond Therapeutics, Inc.·4

Jun 30, 4:05 PM ET

Ni Fang 4

4 · Black Diamond Therapeutics, Inc. · Filed Jun 30, 2022

Insider Transaction Report

Form 4
Period: 2022-06-29
Ni Fang
See Remarks
Transactions
  • Purchase

    Common Stock

    2022-06-29$2.44/sh+25,000$61,01869,026 total
Footnotes (1)
  • [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.394 to $2.5599, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.

Documents

1 file
  • 4
    form4-06302022_010621.xmlPrimary